Ratings
0
Nobody has rated this yet. Be the first!
Works
17
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study
PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type
